Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK221149A in pregnant women with uncomplicated preterm labor
2009-011782-92Phase 2Completed
- Sponsor
- GSK
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Preterm labor (PTL) comparing GSK221149A intravenous with Placebo intravenous (2 arms). Primary endpoint: Maternal safety and tolerability. Started May 2009; status: completed.
02
Drugs
retosiban
03
Conditions
Preterm labor (PTL)
Beyond the preview
Go deeper on 2009-011782-92.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011782-92.